Glenmark Pharmaceuticals gets tentative approval for Dronedarone Tablets, 400 mg
From USFDA
Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration for its Dronedarone Tablets, 400 mg, the generic version of Multaq Tablets, 400 mg of Sanofi- Aventis U.S., LLC.Powered by Capital Market - Live News